InsidersTradesSigma
Follow the 三力制药 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 三力制药 has published 6 insider filings. Market capitalisation: €4.2bn. The latest transaction was disclosed on 4 July 2025 (Sale). Among the most active insiders: 盛永建. Every trade is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€9m
6 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,572 of 29,063 companies
40.4
score / 100
Value35
Quality45
FCF yld3.3%
Earn yld1.1%
EV/EBITDA32.1x
ROE3.2%
Gross mgn70%
Net mgn2.7%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 July 2025
Declarations6 total
6 of 6 declarations
Acerca de 三力制药
Sanli Pharmaceutical es una empresa del sector sanitario y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en el desarrollo y la producción de medicamentos innovadores.